GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats

Journal of Biomedical Research

Volumn 29, Issue 3, 2015, Pages 203-213

  Meng, Guoliang ^a   Wang, Jing ^a   Xiao, Yujiao ^a   Bai, Wenli ^a   Xie, Liping ^a   Shan, Liyang ^a   Moore, Philip K ^b   Ji, Yong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Hydrogen sulfide; Ischemia and reperfusion; Myocardial infarction; Oxidative stress

Indexed keywords

CARDIOVASCULAR AGENT; CASPASE 3; CREATINE KINASE; CYSTATHIONINE GAMMA LYASE; GYY 4137; HYDROGEN SULFIDE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART PROTECTION; HISTOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

EID: 84932129809     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.28.20140037     Document Type: Article

References (33)

1. Jennings RB. Historical perspective on the pathology of myocardial ischemia/reperfusion injury[J]. Circ Res, 2013,113(4):428-438.
2. Vander Heide RS, Steenbergen C. Cardioprotection and myocardial reperfusion: Pitfalls to clinical application[J]. Circ Res, 2013,113(4):464-477.
3. Mozaffari MS, Liu JY, Abebe W, et al. Mechanisms of load dependency of myocardial ischemia reperfusion injury[J]. Am J Cardiovasc Dis, 2013,3(4):180-196.
4. Wang R. Physiological implications of hydrogen sulfide: A whiff exploration that blossomed[J]. Physiol Rev, 2012, 92(2):791-896.
5. Liu YH, Lu M, Hu LF, et al. Hydrogen sulfide in the mammalian cardiovascular system[J]. Antioxid Redox Signal, 2012,17(1):141-185.
6. Tan BH, Wong PT, Bian JS. Hydrogen sulfide: A novel signaling molecule in the central nervous system[J]. Neurochem Int, 2010,56(1):3-10.
7. Wang R. The gasotransmitter role of hydrogen sulfide[J]. Antioxid Redox Signal, 2003,5(4):493-501.
8. Pearson RJ, Wilson T, Wang R. Endogenous hydrogen sulfide and the cardiovascular system-what's the smell all about? Clin Invest Med, 2006,29(3):146-150.
9. Johansen D, Ytrehus K, Baxter GF. Exogenous hydrogen sulfide (h2s) protects against regional myocardial ischemia- reperfusion injury-evidence for a role of k atp channels[J]. Basic Res Cardiol, 2006,101(1):53-60.
10. Bliksoen M, Kaljusto ML, Vaage J, et al. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart[J]. Eur J Cardiothorac Surg, 2008,34(2):344-349.
11. Sivarajah A, McDonald MC, Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat[J]. Shock, 2006,26(2):154-161.
12. Elrod JW, Calvert JW, Morrison J, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function[J]. Proc Natl Acad Sci U S A, 2007,104(39):15560-15565.
13. Bian JS, Yong QC, Pan TT, et al. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes[J]. J Pharmacol Exp Ther, 2006,316(2):670-678.
14. Zhang Z, Huang H, Liu P, et al. Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening k atp channels[J]. Can J Physiol Pharmacol, 2007,85(12):1248-1253.
15. Geng B, Chang L, Pan C, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol[J]. Biochem Biophys Res Commun, 2004,318(3):756-763.
16. Rossoni G, Manfredi B, Tazzari V, et al. Activity of a new hydrogen sulfide-releasing aspirin (acs14) on pathological cardiovascular alterations induced by glutathione depletion in rats[J]. Eur J Pharmacol, 2010,648(1-3):139-145.
17. Li L, Whiteman M, Guan YY, et al. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (gyy4137): New insights into the biology of hydrogen sulfide[J]. Circulation, 2008,117(18):2351-2360.
18. Whiteman M, Li L, Rose P, et al. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages[J]. Antioxid Redox Signal, 2010,12(10):1147-1154.
19. Li L, Bhatia M, Zhu YZ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse[J]. FASEB J, 2005,19(9):1196-1198.
20. Wei WB, Hu X, Zhuang XD, et al. Gyy4137, a novel hydrogen sulfide-releasing molecule, likely protects against high glucose-induced cytotoxicity by activation of the ampk/mtor signal pathway in h9c2 cells[J]. Mol Cell Biochem, 2013,389(1-2):249-256.
21. ChitnisMK,Njie-MbyeYF,OpereCA, et al. Pharmacological actions of the slow release hydrogen sulfide donor gyy4137 on phenylephrine-induced tone in isolated bovine ciliary artery[J]. Exp Eye Res, 2013,116(1):350-354.
22. Liu Z, Han Y, Li L, et al. The hydrogen sulfide donor, gyy4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein e(-/-) mice[J]. Br J Pharmacol, 2013, 169(8):1795-1809.
23. Li ZL, Hu J, Li YL, et al. The effect of hyperoside on the functional recovery of the ischemic/reperfused isolated rat heart: Potential involvement of the extracellular signalregulated kinase 1/2 signaling pathway[J]. Free Radic Biol Med, 2013,57(1):132-140.
24. Kleikers PW, Wingler K, Hermans JJ, et al. Nadph oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury[J]. J Mol Med (Berl), 2012, 90(12):1391-1406.
25. Schofield ZV, Woodruff TM, Halai R, et al. Neutrophils-a key component of ischemia-reperfusion injury[J]. Shock, 2013,40(6):463-470.
26. Wang XL, Liu HR, Tao L, et al. Role of inos-derived reactive nitrogen species and resultant nitrative stress in leukocytes- induced cardiomyocyte apoptosis after myocardial ischemia/reperfusion[J]. Apoptosis, 2007,12(7):1209-1217.
27. de Vries DK, Kortekaas KA, Tsikas D, et al. Oxidative damage in clinical ischemia/reperfusion injury: A reappraisal[J]. Antioxid Redox Signal, 2013,19(6): 535-545.
28. Xu W, Wu W, Chen J, et al. Exogenous hydrogen sulfide protects h9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 mapk and erk1/2 pathways[J]. Int J Mol Med, 2013,32(4): 917-925.
29. Peake BF, Nicholson CK, Lambert JP, et al. Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating nrf2 signaling in an erk-dependent manner[J]. Am J Physiol Heart Circ Physiol, 2013,304(9):H1215-1224.
30. Hu Y, Chen X, Pan TT, et al. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of erk and pi3k/akt pathways[J]. Pflugers Arch, 2008,455(4): 607-616.
31. Guo C, Liang F, Shah Masood W, et al. Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by keap1 s-sulfhydration, mapk dependent antiapoptosis and nf-kappab dependent anti-inflammation pathway[J]. Eur J Pharmacol, 2014,725(1):70-78.
32. Xu T, Li D, Jiang D. Targeting cell signaling and apoptotic pathways by luteolin: Cardioprotective role in rat cardiomyocytes following ischemia/reperfusion[J]. Nutrients, 2012,4(12):2008-2019.
33. Yao X, Tan G, He C, et al. Hydrogen sulfide protects cardiomyocytes from myocardial ischemia-reperfusion injury by enhancing phosphorylation of apoptosis repressor with caspase recruitment domain[J]. Tohoku J Exp Med, 2012, 226(4):275-285.